Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

Completed · Phase 3

Conditions studied: Diabetes Mellitus

In brief

The purpose of the study is to compare the effect in blood sugar control between Lantus and twice daily intermediate acting insulins (NPH or Lente) when used as the basal insulin in a multiple daily injection setting with fast acting insulin (Lispro)

Key facts

Study ID

NCT00046501

Run by

Sanofi

People needed

250

Starts

2002-11-01

Last updated by the study team

2011-01-11

Who can join

Age: 9 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Type 1 diabetes treated with insulin only for at least 1 year,
• with a Tanner stage of ≥ 2,
• had evidence of decreased insulin secretory capacity (fasting C-peptide concentration ≤0.5 mmol/L) and 7.0%≤A1c≤9.5% at screening.
• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Where it is running

• Aventis — Bridgewater, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.